Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
The Journal of Trauma and Acute Care Surgery|September 20, 2021
The patient's voice matters: The impact of advance directives on elderly trauma patientsJanet S Lee, Abid D Khan, Warren C Dorlac, et al.
Public Health Action|March 23, 2022
Thoracic ultrasound for TB diagnosis in adults and childrenM Fentress, P C Henwood, P Maharaj, et al.
Transplantation Direct|November 18, 2020
Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic SteatohepatitisSanjaya K Satapathy, Pratik Banerjee, Joseph F Pierre, et al.
Critical Pathways in Cardiology|September 18, 2020
Oral Antiplatelet Therapy Administered Upstream to Patients With NSTEMICharles V Pollack, W Frank Peacock, Durgesh D Bhandary, et al.
JAMA Cardiology|March 5, 2020
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
JAMA Cardiology|November 14, 2019
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphomaKhuda D Khan, Christos Emmanouilides, Don M Benson, et al.
The Journal of Trauma and Acute Care Surgery|September 7, 2018
Clearing the cervical spine in patients with distracting injuries: An AAST multi-institutional trialAbid D Khan, Sean C Liebscher, Hannah C Reiser, et al.
JAMA Network Open|September 10, 2024
Estimated Health and Economic Outcomes of Racial and Ethnic Tuberculosis Disparities in US-Born PersonsNicole A Swartwood, Yunfei Li, Mathilda Regan, et al.
Cancer|April 4, 2003
Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseasesFrancis J Giles, Maureen A Cooper, Lewis Silverman, et al.
Pageof 20